Stay updated with breaking news from Andreaf Wainer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Raymond James reiterated their buy rating on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a report released on Wednesday morning, Stock Target Advisor reports. They currently have a $124.00 price objective on the healthcare product maker’s stock. Several other equities analysts have also weighed in on the stock. Royal Bank of Canada cut […]
WD Rutherford LLC trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 10,968 shares of the healthcare product maker’s stock after selling 215 shares during the period. WD Rutherford LLC’s holdings in Abbott Laboratories were worth $1,252,000 as of […]
Overbrook Management Corp increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,804 shares of the healthcare product maker’s stock after acquiring an additional 900 shares during the period. Overbrook Management […]
Overbrook Management Corp increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 13.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,804 shares of the healthcare product maker’s stock after purchasing an additional 900 shares during the period. Overbrook Management […]
O Brien Greene & Co. Inc cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,689 shares of the healthcare product maker’s stock after selling 125 shares during the period. […]